RecruitingPhase 4NCT06260007
Efficacy and Safety Study of Products Based on Tribulus Terrestris, L. in Men With Oligospermia
Sponsor
Herbarium Laboratorio Botanico Ltda
Enrollment
204 participants
Start Date
Jul 12, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Efficacy and Safety of Products Based on Tribulus terrestris, L. in Men with Oligospermia. It is expected that the benefits of investigational products outweigh the risks that will be mitigated or carefully managed by the study team.
Eligibility
Sex: MALEMin Age: 25 YearsMax Age: 60 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying Placebo and a drug called Tribulus terrestris for people with oligospermia. The study is currently recruiting participants at 1 location. People eligible for this study include men aged 25 Years to 60 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGTribulus terrestris
Tribulus terrestris
OTHERPlacebo
Placebo
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06260007
Related Trials
Hyperbaric Oxygen Therapy for Men Suffering From Infertility Due to Oligospermia.
NCT058422391 location
Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI)
NCT073577012 locations
Study of Tolerability, Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Medicinal Product MediReg®
NCT068698631 location